Cargando…
Reduced 123I Ioflupane Binding in Bilateral Diabetic Chorea: Findings With 18F FDG PET, 99mTc ECD SPECT, and 123I MIBG Scintigraphy
We report a 64-year-old man with diabetic chorea whom we investigated with dopamine transporter SPECT, (18)F FDG PET, (99m)Tc ethylcysteinate dimer (ECD) SPECT, and (123)I metaiodobenzylguanidine (MIBG) scintigraphy. Dopamine transporter SPECT revealed reduced (123)I ioflupane binding in the bilater...
Autores principales: | Sato, Kenichiro, Hida, Ayumi, Kameyama, Masashi, Morooka, Miyako, Takeuchi, Sousuke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859201/ https://www.ncbi.nlm.nih.gov/pubmed/26975011 http://dx.doi.org/10.1097/RLU.0000000000001202 |
Ejemplares similares
-
(123)I-ioflupane brain SPECT and (123)I-MIBG cardiac planar scintigraphy combined use in uncertain parkinsonian disorders
por: Nuvoli, Susanna, et al.
Publicado: (2017) -
Importance of (123)I-ioflupane SPECT and Myocardial MIBG Scintigraphy to Determine the Candidate of Deep Brain Stimulation for Parkinson’s Disease
por: ASAHI, Takashi, et al.
Publicado: (2016) -
CT-Based Attenuation Correction in I-123-Ioflupane SPECT
por: Lange, Catharina, et al.
Publicado: (2014) -
Diagnosis of dementia with Lewy bodies: diagnostic performance of combined (123)I-IMP brain perfusion SPECT and (123)I-MIBG myocardial scintigraphy
por: Sakamoto, Fumi, et al.
Publicado: (2013) -
Discriminating among degenerative parkinsonisms using advanced (123)I-ioflupane SPECT analyses
por: Badoud, Simon, et al.
Publicado: (2016)